Clinical Trial Update: Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer [NA]

View source ↗

Summary

This clinical trial update indicates ongoing recruitment to evaluate the safety and efficacy of recombinant human thyroid-stimulating hormone as an adjuvant dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Recombinant Human Thyroid Stimulating Hormone (thyrotropin alfa)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Recombinant Human Thyroid Stimulating Hormone | NA | Status: RECRUITING